Professional Medical Expertise Company SJSC

Professional Medical Expertise Company SJSC maintains a debt-to-equity ratio of 0.84, indicating a moderate reliance on debt financing. The company's current ratio of 1.55 suggests it has sufficient short-term assets to cover its short-term liabilities, though its operating cash flow of SAR 715,290 is relatively low compared to its total liabilities of SAR 272,422,130. The company's free cash flow of SAR 22,581,800 provides some flexibility for reinvestment or debt reduction, but its capital expenditure of SAR -24,231,560 indicates a net outflow from investment activities. In terms of profitability, the company's return on equity of 27.77% and return on assets of 9.87% are strong, outperforming the typical industry benchmarks for medical equipment and distribution firms. The net income of SAR 41,707,610 and operating income of SAR 59,593,870 reflect a healthy margin structure, with a gross profit of SAR 184,990,170 supporting these results. These metrics suggest the company is effectively managing its costs and generating returns from its asset base. The company's revenue of SAR 418,778,780 is derived from a broad range of medical device segments, including spine, sports medicine, pediatric orthopedic, oncology, general surgery, endoscopy, and bariatric surgery. While the input data does not specify the exact revenue contribution from each segment, the diversified product portfolio suggests a balanced exposure to different areas of the medical equipment market. The company's geographic exposure is primarily concentrated in Saudi Arabia, with no disclosed international operations. The company's growth trajectory is not explicitly outlined in the input data, but its current revenue level and profitability suggest a stable operating model. The input data does not provide forward-looking guidance or next fiscal year projections, so the growth outlook remains speculative. However, the company's strong return on equity and free cash flow position it to potentially reinvest in its operations or expand its product offerings. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint, as the company's cash reserves may not be sufficient to cover its debt obligations without external financing. The low dilution risk suggests that the company is not currently issuing new shares at a rate that would significantly dilute existing shareholders' equity. Recent events and filings are not explicitly detailed in the input data, but the company's financial snapshot and risk assessment suggest a stable but cautious financial position. The company's operating cash flow and free cash flow are positive, but the negative net cash position after debt indicates a need for careful liquidity management.